| Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility | Annual Review of Immunology | 2005 | 666 |
| Cocaine in surface waters: a new evidence-based tool to monitor community drug abuse | Environmental Health | 2005 | 354 |
| A multiresidue analytical method using solid-phase extraction and high-pressure liquid chromatography tandem mass spectrometry to measure pharmaceuticals of different therapeutic classes in urban wastewaters | Journal of Chromatography A | 2005 | 315 |
| Identification of the pharmaceuticals for human use contaminating the Italian aquatic environment | Journal of Hazardous Materials | 2005 | 296 |
| Variation in the carotid bifurcation geometry of young versus older adults: implications for geometric risk of atherosclerosis | Stroke | 2005 | 167 |
| Increased inflammation in mice deficient for the chemokine decoy receptor D6 | European Journal of Immunology | 2005 | 119 |
| Junctional adhesion molecule-A-deficient polymorphonuclear cells show reduced diapedesis in peritonitis and heart ischemia-reperfusion injury | Proceedings of the National Academy of Sciences of the United States of America | 2005 | 98 |
| Proteome analysis for the identification of in vivo estrogen-regulated proteins in bone | Proteomics | 2005 | 37 |
| Strategies for national health care systems in emerging countries: the case of screening and prevention of renal disease progression in Bolivia | Kidney International | 2005 | 31 |
| High-performance liquid chromatography with ultraviolet detection for therapeutic drug monitoring of everolimus | Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences | 2005 | 30 |
| 4-Aminobiphenyl-hemoglobin adducts and risk of smoking-related disease in never smokers and former smokers in the European Prospective Investigation into Cancer and Nutrition prospective study | Cancer Epidemiology Biomarkers and Prevention | 2005 | 28 |
| Generic cyclosporine formulations: more open questions than answers | Transplant International | 2005 | 25 |
| Severe early acute humoral rejection resulting in allograft loss in a renal transplant recipient with Campath-1H induction therapy | Nephrology Dialysis Transplantation | 2005 | 22 |
| Dual blockade of the renin-angiotensin system: the ultimate treatment for renal protection? | Journal of the American Society of Nephrology: JASN | 2005 | 22 |
| Hyperuricemia in kidney transplantation | Contributions To Nephrology | 2005 | 20 |
| Pathophysiology of disease progression in proteinuric nephropathies | Kidney International | 2005 | 20 |
| Comparison of different cyclosporine immunoassays to monitor C0 and C2 blood levels from kidney transplant recipients: not simply overestimation | Clinica Chimica Acta | 2005 | 15 |
| The future of renoprotection | Kidney International | 2005 | 15 |
| Prevention of progression and remission/regression strategies for chronic renal diseases: can we do better now than five years ago? | Kidney International | 2005 | 14 |
| Lipid oxidative stress and the anti-inflammatory properties of statins and ACE inhibitors | Journal of Renal Nutrition | 2005 | 12 |
| Cyclosporine formulation and Kaposi's sarcoma after renal transplantation | Transplantation | 2005 | 12 |
| Emerging drugs for diabetic nephropathy | Expert Opinion on Emerging Drugs | 2005 | 8 |
| Autologous stem cell and kidney transplantation for primary amyloidosis associated with ESRD: which should come first? | American Journal of Transplantation | 2005 | 5 |
| Chronic allograft nephropathy. A multiple approach to target nonimmunological factors | Contributions To Nephrology | 2005 | 4 |
| Kidney prevention recipes for your office practice | Kidney International | 2005 | 1 |
